Pregled bibliografske jedinice broj: 714247
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients // World journal of gastroenterology, 11 (2005), 15; 2334-2336 doi:10.3748/wjg.v11.i15.2334 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 714247 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients
Autori
Marušić, Marinko ; Babić, Žarko ; Nesanović, Mirjana ; Mlinac-Lucijanić, Mira ; Štajcar, Vlado
Izvornik
World journal of gastroenterology (1007-9327) 11
(2005), 15;
2334-2336
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
H.Pylori ; intestinal metaplasia
Sažetak
AIM: Intestinal metaplasia (IM) is more often found in patients with Helicobacter pylori (H pylori) infection, while eradication of H pylori results in significant reduction in the severity and activity of chronic gastritis. We aimed to determine in patients with unsuccessful eradication of H pylori the role of various proton pump inhibitors (PPIs) having different mechanisms in the resolution of IM. METHODS: We confirmed endoscopically and pathohistologically (Sydney classification) the IM in 335 patients with gastritis before and after medication for eradication of H pylori (Maastricht Protocol 2002). H pylori infection was determined by using histology, urease test and culture. Control endoscopy and histology were done after 30 d and thereafter (within 1 year). Unsuccessful eradication was considered if only one of the three tests (histology, urease and culture) was negative after therapy protocol. We used omeprazole, pantoprazole, lansoprazole in therapy protocols (in combination with two antibiotics). RESULTS: We found no significant difference in resolution of IM by using different PPI between the groups of eradicated and noneradicated patients (P<0.4821 and P<0.4388, respectively). CONCLUSION: There is no significant difference in resolution of intestinal metaplasia by different proton pump inhibitors.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Sveti Duh",
Opća bolnica Karlovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE